Your browser doesn't support javascript.
loading
Collaborative study using common samples to evaluate the performance of anti-drug antibody assays constructed by different companies.
Niimi, Shingo; Nishimiya, Kazuhiro; Nishidate, Masanobu; Saito, Tetsu; Minoura, Kyoko; Kadotsuji, Kenta; Shimakura, Jin; Shigemizu, Hiroko; Hosogi, Jun; Adachi, Maiko; Hashimoto, Tsutomu; Mori, Tamiki; Harada, Hideki; Yamamoto, Ken-Ichi; Nakamura, Takahiro; Nomura, Tatsuki; Yamaguchi, Itadaki; Sonehara, Kazuhiko; Ishii-Watabe, Akiko; Kawasaki, Nana.
Afiliación
  • Niimi S; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: niimi19551113@gmail.com.
  • Nishimiya K; Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura City, Kanagawa, 247-8530, Japan.
  • Nishidate M; Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura City, Kanagawa, 247-8530, Japan.
  • Saito T; Astellas Pharma Inc., 21 Miyukigaoka, Tsukubashi, Ibaraki, 305-8585, Japan.
  • Minoura K; Astellas Pharma Inc., 21 Miyukigaoka, Tsukubashi, Ibaraki, 305-8585, Japan.
  • Kadotsuji K; Sumitomo Dainippon Pharma Co., Ltd, 33-94 Enokicho, Suita-shi, Osaka, 554-0022, Japan.
  • Shimakura J; Sumitomo Dainippon Pharma Co., Ltd, 1-13-1 Kyobashi, Chuo-ku, Tokyo, 104-8356, Japan.
  • Shigemizu H; CMIC Pharma Science Co., Ltd, Formerly JCL Bioassay Corporation, 17-18, Nakahata-cho, Nishiwaki-shi, Hyogo, 677-0032, Japan.
  • Hosogi J; Kyowa Hakko Kirin Co., Ltd, 1188, Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-9731, Japan.
  • Adachi M; Kyowa Hakko Kirin Co., Ltd, 1188, Shimotogari, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-9731, Japan.
  • Hashimoto T; LSI Medience Corporation, 30-1, Shimura 3-chome, Itabashi-ku, Tokyo, 174-8555, Japan.
  • Mori T; LSI Medience Corporation, 30-1, Shimura 3-chome, Itabashi-ku, Tokyo, 174-8555, Japan.
  • Harada H; LSI Medience Corporation, 14-1 Sunayama, Kamisu, Ibaraki, 314-0255, Japan.
  • Yamamoto KI; LSI Medience Corporation, 1285 Kurisaki-machi, Uto, Kumamoto, 869-0425, Japan.
  • Nakamura T; Shin Nippon Biomedicals Laboratories, Ltd, 2438 Miyanoura, Kagoshima, 891-1394, Japan.
  • Nomura T; Shin Nippon Biomedicals Laboratories, Ltd, 2438 Miyanoura, Kagoshima, 891-1394, Japan.
  • Yamaguchi I; Sumika Chemical Analysis Service, Ltd, 3-1-135 Kasugadenaka, Konohana-ku, Osaka, 554-0022, Japan.
  • Sonehara K; Sumika Chemical Analysis Service, Ltd, 3-1-135 Kasugadenaka, Konohana-ku, Osaka, 554-0022, Japan.
  • Ishii-Watabe A; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku Kawasaki-shi, Kanagawa, 210-9501, Japan.
  • Kawasaki N; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku Kawasaki-shi, Kanagawa, 210-9501, Japan; Graduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.
Drug Metab Pharmacokinet ; 33(2): 125-132, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29610053
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Inmunosupresores Límite: Humans Idioma: En Revista: Drug Metab Pharmacokinet Asunto de la revista: FARMACOLOGIA / METABOLISMO Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Inmunosupresores Límite: Humans Idioma: En Revista: Drug Metab Pharmacokinet Asunto de la revista: FARMACOLOGIA / METABOLISMO Año: 2018 Tipo del documento: Article